PATEL DHAVALKUMAR DHIRAJLAL
SEC insider (Form 3/4/5 filer). CIK 0002115339. EVP, Chief Scientific Officer at Sana Biotechnology, Inc. (SANA). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in SEATTLE, WA.
Companies PATEL DHAVALKUMAR DHIRAJLAL has filed insider reports for
- Sana Biotechnology, Inc. (SANA): Officer, EVP, Chief Scientific Officer
PATEL DHAVALKUMAR DHIRAJLAL
CIK: 0002115339
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SANA
Sana Biotechnology, Inc.
Officer